Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of Ga-68 Radiolabeled Dota Functionalized and Acetylated Pamam Dendrimer-Coated Iron Oxide Nanoparticles As Pet/Mr Dual-Modal Imaging Agent Publisher



Almasi T1 ; Gholipour N2, 3 ; Akhlaghi M4 ; Mokhtari Kheirabadi A4 ; Mazidi SM5 ; Hosseini SH6 ; Geramifar P4 ; Beiki D4 ; Rostampour N1 ; Shahbazi Gahrouei D7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  3. 3. Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran
  4. 4. Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran
  6. 6. Department of Chemical Engineering, University of Science and Technology of Mazandaran, Behshahr, Iran
  7. 7. Department of Medical Physics, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran

Source: International Journal of Polymeric Materials and Polymeric Biomaterials Published:2021


Abstract

Gallium-68 radiolabeled DOTA- acetyl-PAMAM coated iron oxide nanoparticles (NPs) were developed as dual-modality agents for PET-MR imaging. The increase in the chelator content, acetylation step, and radiolabeling condition had distinctive effects on the physical, biological, and radiochemical properties of NPs. The r2 relaxivity coefficient value of the NPs was 96.7 mM−1s−1. High accumulation of candidate NPs was in the liver and spleen and about 3.4% ID/g uptake (tissue sampling), and a distinctive uptake (PET-CT image) were observed in the tumor site. These NPs could be used as the dual-modality agent for the diagnosis of the tumors via PET-MR imaging. © 2020 Taylor & Francis Group, LLC.